Research Update: A Systematic Review of the Relationship Between Eating Disorder Symptoms and Parental Socioeconomic Status (SES) Among Adolescents
Abstract
Objective: Eating disorders (EDs) have long been viewed as disorders affecting higher socioeconomic groups, yet recent evidence shows they occur across all backgrounds. This systematic review and meta-analysis aims to evaluate the relationship between parental socioeconomic status (SES) and ED symptoms in adolescents in the general population. As a secondary aim, we will study how parental SES is measured in community-based studies and identify which SES indicators are most relevant for understanding adolescent ED risk.
Method: A PRISMA search was carried out via Web of Science, Scopus, MEDLINE, Embase, PsycINFO, and ProQuest to identify quantitative studies examining the relationship between parental SES and adolescent ED symptoms in Western countries. The search produced 56,653 records, and 51 articles published from January 2000 onwards met inclusion criteria.
Results: Parental education was the most used SES measure across the included studies (> 50%). Our meta-analysis revealed a significantly lower likelihood of ED symptoms in adolescents of parents with higher educational backgrounds (OR = 0.83, 95% CI: 0.72-0.95, p = 0.007). Household income was generally negatively associated with ED symptoms in adolescents, particularly with binge eating behaviors. Findings related to SES indexes and other proxies were inconsistent.
Discussion: Adolescents from lower education and lower income households are more likely to present with ED symptoms. Findings highlight the influence…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.